Literature DB >> 1321511

Transforming growth factor beta (TGF-beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line.

J H Hassan1, C Chelucci, C Peschle, V Sorrentino.   

Abstract

We have investigated the effect(s) of transforming growth factor (TGF)-beta 1 and interleukin (IL)-6 on the expression of fibrinogen and blood coagulation factors VII, IX, X mRNAs in a hepatoma cell line (Hep 3B). The results indicate that TGF-beta induces a decrease of the basal level of fibrinogen and factor VII mRNAs, but does not affect factor X expression. Furthermore, TGF-beta efficiently antagonizes the IL-6 induction of fibrinogen mRNA at late (12-48 h) but not early (6 h) times: this effect is apparently mediated by posttranscriptional mechanism(s). These findings, together with previously reported data on the inhibitory effect of TGF-beta on acute phase genes (e.g., ApoA1 and albumin), suggest a role for TGF-beta in the regulation of liver genes expression. The early stimulatory and late inhibitory effect exerted by IL-6 and TGF-beta respectively on fibrinogen mRNA level may play a role in the regulatory mechanism(s) of clot formation in a variety of conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321511

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Genetic Modulation of Plasma Fibrinogen Concentrations: Possible Importance of Interleukin-6.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Authors:  Chantelle M Rein-Smith; Nathan W Anderson; David H Farrell
Journal:  Thromb Res       Date:  2012-10-01       Impact factor: 3.944

3.  Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity.

Authors:  Syed K Rafi; Jeremy P Goering; Adam J Olm-Shipman; Lauren A Hipp; Nicholas J Ernst; Nathan R Wilson; Everett G Hall; Sumedha Gunewardena; Irfan Saadi
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.